$0.47▾ 10.19%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-16.35MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
67th pctvs its own history
Fair
Its valuation is around the middle of its own recent range.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
GlucoTrack, Inc. is pre-profit. It is still burning cash while pre-profit. Its valuation is around the middle of its own recent range.
Key numbers
Valuation
EPS (TTM)$18.04
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$0.00
TTM (trailing 12 months, through fiscal Q1 FY2026)
Recent news
Sentiment · last 30 days2 articles
2 bullish0 neutral0 bearish
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.